XML 61 R46.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Condensed Consolidating Financial Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017
Condensed Financial Information of Parent Company Only Disclosure [Abstract] |
Condensed Consolidating Statement of Operations |
| For the Year Ended December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 21.3 |  |  | $ | 2,258.7 |  |  | $ | 1,817.5 |  |  | $ | (126.1 | ) |  | $ | 3,971.4 |
Less: Provision for doubtful accounts | — |  |  | (30.7 | ) |  | (21.7 | ) |  | — |  |  | (52.4 | )
Net operating revenues less provision for doubtful accounts | 21.3 |  |  | 2,228.0 |  |  | 1,795.8 |  |  | (126.1 | ) |  | 3,919.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 34.7 |  |  | 1,077.4 |  |  | 1,063.5 |  |  | (21.0 | ) |  | 2,154.6 |
Other operating expenses | 32.8 |  |  | 321.8 |  |  | 230.7 |  |  | (48.6 | ) |  | 536.7 |
Occupancy costs | 1.9 |  |  | 93.4 |  |  | 34.7 |  |  | (56.5 | ) |  | 73.5 |
Supplies | — |  |  | 93.2 |  |  | 56.1 |  |  | — |  |  | 149.3 |
General and administrative expenses | 143.7 |  |  | — |  |  | 28.0 |  |  | — |  |  | 171.7 |
Depreciation and amortization | 8.8 |  |  | 103.4 |  |  | 71.6 |  |  | — |  |  | 183.8 |
Total operating expenses | 221.9 |  |  | 1,689.2 |  |  | 1,484.6 |  |  | (126.1 | ) |  | 3,269.6 |
Loss on early extinguishment of debt | 10.7 |  |  | — |  |  | — |  |  | — |  |  | 10.7 |
Interest expense and amortization of debt discounts and fees | 130.5 |  |  | 21.1 |  |  | 23.8 |  |  | (21.0 | ) |  | 154.4 |
Other (income) loss | (21.7 | ) |  | 0.2 |  |  | (3.6 | ) |  | 21.0 |  |  | (4.1 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (7.3 | ) |  | (0.7 | ) |  | — |  |  | (8.0 | )
Equity in net income of consolidated affiliates | (341.6 | ) |  | (40.3 | ) |  | — |  |  | 381.9 |  |  | — |
Management fees | (145.0 | ) |  | 108.3 |  |  | 36.7 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 166.5 |  |  | 456.8 |  |  | 255.0 |  |  | (381.9 | ) |  | 496.4 |
Provision for income tax (benefit) expense | (90.2 | ) |  | 182.3 |  |  | 68.5 |  |  | — |  |  | 160.6 |
Income from continuing operations | 256.7 |  |  | 274.5 |  |  | 186.5 |  |  | (381.9 | ) |  | 335.8 |
Loss from discontinued operations, net of tax | (0.4 | ) |  | — |  |  | — |  |  | — |  |  | (0.4 | )
Net income | 256.3 |  |  | 274.5 |  |  | 186.5 |  |  | (381.9 | ) |  | 335.4 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (79.1 | ) |  | — |  |  | (79.1 | )
Net income attributable to Encompass Health | $ | 256.3 |  |  | $ | 274.5 |  |  | $ | 107.4 |  |  | $ | (381.9 | ) |  | $ | 256.3 |
Comprehensive income | $ | 256.2 |  |  | $ | 274.5 |  |  | $ | 186.5 |  |  | $ | (381.9 | ) |  | $ | 335.3 |
Comprehensive income attributable to Encompass Health | $ | 256.2 |  |  | $ | 274.5 |  |  | $ | 107.4 |  |  | $ | (381.9 | ) |  | $ | 256.2 |
| For the Year Ended December 31, 2016
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 20.1 |  |  | $ | 2,171.7 |  |  | $ | 1,633.3 |  |  | $ | (117.9 | ) |  | $ | 3,707.2 |
Less: Provision for doubtful accounts | — |  |  | (41.8 | ) |  | (19.4 | ) |  | — |  |  | (61.2 | )
Net operating revenues less provision for doubtful accounts | 20.1 |  |  | 2,129.9 |  |  | 1,613.9 |  |  | (117.9 | ) |  | 3,646.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 45.5 |  |  | 1,006.1 |  |  | 952.6 |  |  | (18.3 | ) |  | 1,985.9 |
Other operating expenses | 25.5 |  |  | 309.8 |  |  | 203.1 |  |  | (46.3 | ) |  | 492.1 |
Occupancy costs | 2.9 |  |  | 89.8 |  |  | 31.9 |  |  | (53.3 | ) |  | 71.3 |
Supplies | — |  |  | 89.9 |  |  | 50.1 |  |  | — |  |  | 140.0 |
General and administrative expenses | 126.7 |  |  | — |  |  | 6.7 |  |  | — |  |  | 133.4 |
Depreciation and amortization | 9.4 |  |  | 102.8 |  |  | 60.4 |  |  | — |  |  | 172.6 |
Professional fees—accounting, tax, and legal | 1.9 |  |  | — |  |  | — |  |  | — |  |  | 1.9 |
Total operating expenses | 211.9 |  |  | 1,598.4 |  |  | 1,304.8 |  |  | (117.9 | ) |  | 2,997.2 |
Loss on early extinguishment of debt | 7.4 |  |  | — |  |  | — |  |  | — |  |  | 7.4 |
Interest expense and amortization of debt discounts and fees | 147.3 |  |  | 21.6 |  |  | 23.1 |  |  | (19.9 | ) |  | 172.1 |
Other income | (19.6 | ) |  | (0.4 | ) |  | (2.8 | ) |  | 19.9 |  |  | (2.9 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (9.0 | ) |  | (0.8 | ) |  | — |  |  | (9.8 | )
Equity in net income of consolidated affiliates | (347.2 | ) |  | (41.2 | ) |  | — |  |  | 388.4 |  |  | — |
Management fees | (136.2 | ) |  | 103.1 |  |  | 33.1 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 156.5 |  |  | 457.4 |  |  | 256.5 |  |  | (388.4 | ) |  | 482.0 |
Provision for income tax (benefit) expense | (91.1 | ) |  | 182.6 |  |  | 72.4 |  |  | — |  |  | 163.9 |
Income from continuing operations | 247.6 |  |  | 274.8 |  |  | 184.1 |  |  | (388.4 | ) |  | 318.1 |
Income from discontinued operations, net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income | 247.6 |  |  | 274.8 |  |  | 184.1 |  |  | (388.4 | ) |  | 318.1 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (70.5 | ) |  | — |  |  | (70.5 | )
Net income attributable to Encompass Health | $ | 247.6 |  |  | $ | 274.8 |  |  | $ | 113.6 |  |  | $ | (388.4 | ) |  | $ | 247.6 |
Comprehensive income | $ | 247.6 |  |  | $ | 274.8 |  |  | $ | 184.1 |  |  | $ | (388.4 | ) |  | $ | 318.1 |
Comprehensive income attributable to Encompass Health | $ | 247.6 |  |  | $ | 274.8 |  |  | $ | 113.6 |  |  | $ | (388.4 | ) |  | $ | 247.6 |
| For the Year Ended December 31, 2015
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 19.4 |  |  | $ | 1,871.6 |  |  | $ | 1,375.4 |  |  | $ | (103.5 | ) |  | $ | 3,162.9 |
Less: Provision for doubtful accounts | — |  |  | (33.7 | ) |  | (13.5 | ) |  | — |  |  | (47.2 | )
Net operating revenues less provision for doubtful accounts | 19.4 |  |  | 1,837.9 |  |  | 1,361.9 |  |  | (103.5 | ) |  | 3,115.7 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 49.4 |  |  | 866.7 |  |  | 771.8 |  |  | (17.1 | ) |  | 1,670.8 |
Other operating expenses | 31.3 |  |  | 266.2 |  |  | 175.9 |  |  | (41.3 | ) |  | 432.1 |
Occupancy costs | 4.0 |  |  | 66.9 |  |  | 28.1 |  |  | (45.1 | ) |  | 53.9 |
Supplies | — |  |  | 82.8 |  |  | 45.9 |  |  | — |  |  | 128.7 |
General and administrative expenses | 128.3 |  |  | — |  |  | 5.0 |  |  | — |  |  | 133.3 |
Depreciation and amortization | 9.9 |  |  | 82.8 |  |  | 47.0 |  |  | — |  |  | 139.7 |
Government, class action, and related settlements | 7.5 |  |  | — |  |  | — |  |  | — |  |  | 7.5 |
Professional fees—accounting, tax, and legal | 3.0 |  |  | — |  |  | — |  |  | — |  |  | 3.0 |
Total operating expenses | 233.4 |  |  | 1,365.4 |  |  | 1,073.7 |  |  | (103.5 | ) |  | 2,569.0 |
Loss on early extinguishment of debt | 22.4 |  |  | — |  |  | — |  |  | — |  |  | 22.4 |
Interest expense and amortization of debt discounts and fees | 130.0 |  |  | 11.2 |  |  | 13.1 |  |  | (11.4 | ) |  | 142.9 |
Other income | (13.6 | ) |  | (0.2 | ) |  | (3.1 | ) |  | 11.4 |  |  | (5.5 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (8.5 | ) |  | (0.2 | ) |  | — |  |  | (8.7 | )
Equity in net income of consolidated affiliates | (320.4 | ) |  | (40.3 | ) |  | — |  |  | 360.7 |  |  | — |
Management fees | (119.7 | ) |  | 88.8 |  |  | 30.9 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 87.3 |  |  | 421.5 |  |  | 247.5 |  |  | (360.7 | ) |  | 395.6 |
Provision for income tax (benefit) expense | (96.9 | ) |  | 168.2 |  |  | 70.6 |  |  | — |  |  | 141.9 |
Income from continuing operations | 184.2 |  |  | 253.3 |  |  | 176.9 |  |  | (360.7 | ) |  | 253.7 |
(Loss) income from discontinued operations, net of tax | (1.1 | ) |  | — |  |  | 0.2 |  |  | — |  |  | (0.9 | )
Net income | 183.1 |  |  | 253.3 |  |  | 177.1 |  |  | (360.7 | ) |  | 252.8 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (69.7 | ) |  | — |  |  | (69.7 | )
Net income attributable to Encompass Health | $ | 183.1 |  |  | $ | 253.3 |  |  | $ | 107.4 |  |  | $ | (360.7 | ) |  | $ | 183.1 |
Comprehensive income | $ | 182.4 |  |  | $ | 253.3 |  |  | $ | 177.1 |  |  | $ | (360.7 | ) |  | $ | 252.1 |
Comprehensive income attributable to Encompass Health | $ | 182.4 |  |  | $ | 253.3 |  |  | $ | 107.4 |  |  | $ | (360.7 | ) |  | $ | 182.4 |
Condensed Consolidating Balance Sheet |
| As of December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash | — |  |  | — |  |  | 62.4 |  |  | — |  |  | 62.4 |
Accounts receivable, net | — |  |  | 285.2 |  |  | 186.9 |  |  | — |  |  | 472.1 |
Prepaid expenses and other current assets | 61.4 |  |  | 21.7 |  |  | 48.7 |  |  | (18.5 | ) |  | 113.3 |
Total current assets | 95.7 |  |  | 309.8 |  |  | 315.2 |  |  | (18.5 | ) |  | 702.2 |
Property and equipment, net | 101.8 |  |  | 991.5 |  |  | 423.8 |  |  | — |  |  | 1,517.1 |
Goodwill | — |  |  | 854.6 |  |  | 1,118.0 |  |  | — |  |  | 1,972.6 |
Intangible assets, net | 11.8 |  |  | 105.1 |  |  | 286.2 |  |  | — |  |  | 403.1 |
Deferred income tax assets | 97.4 |  |  | 8.4 |  |  | — |  |  | (42.2 | ) |  | 63.6 |
Other long-term assets | 49.2 |  |  | 100.5 |  |  | 85.4 |  |  | — |  |  | 235.1 |
Intercompany notes receivable | 486.2 |  |  | — |  |  | — |  |  | (486.2 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,839.1 |  |  | 311.3 |  |  | — |  |  | (3,150.4 | ) |  | — |
Total assets | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 32.8 |  |  | $ | 7.4 |  |  | $ | 9.6 |  |  | $ | (17.5 | ) |  | $ | 32.3 |
Accounts payable | 10.4 |  |  | 43.5 |  |  | 24.5 |  |  | — |  |  | 78.4 |
Accrued payroll | 36.1 |  |  | 63.8 |  |  | 72.2 |  |  | — |  |  | 172.1 |
Accrued interest payable | 21.9 |  |  | 2.6 |  |  | 0.2 |  |  | — |  |  | 24.7 |
Other current liabilities | 108.8 |  |  | 15.6 |  |  | 86.6 |  |  | (1.0 | ) |  | 210.0 |
Total current liabilities | 210.0 |  |  | 132.9 |  |  | 193.1 |  |  | (18.5 | ) |  | 517.5 |
Long-term debt, net of current portion | 2,258.5 |  |  | 242.2 |  |  | 44.7 |  |  | — |  |  | 2,545.4 |
Intercompany notes payable | — |  |  | — |  |  | 486.2 |  |  | (486.2 | ) |  | — |
Self-insured risks | 9.6 |  |  | — |  |  | 100.5 |  |  | — |  |  | 110.1 |
Other long-term liabilities | 21.4 |  |  | 17.8 |  |  | 78.1 |  |  | (42.1 | ) |  | 75.2 |
Intercompany payable | — |  |  | — |  |  | 144.8 |  |  | (144.8 | ) |  | — |
| 2,499.5 |  |  | 392.9 |  |  | 1,047.4 |  |  | (691.6 | ) |  | 3,248.2 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 220.9 |  |  | — |  |  | 220.9 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 717.4 |  |  | (3,005.7 | ) |  | 1,181.7 |
Noncontrolling interests | — |  |  | — |  |  | 242.9 |  |  | — |  |  | 242.9 |
Total shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 960.3 |  |  | (3,005.7 | ) |  | 1,424.6 |
Total liabilities and shareholders’ equity | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
| As of December 31, 2016
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 18.3 |  |  | $ | — |  |  | $ | 40.5 |
Restricted cash | — |  |  | — |  |  | 60.9 |  |  | — |  |  | 60.9 |
Accounts receivable, net | — |  |  | 273.3 |  |  | 170.5 |  |  | — |  |  | 443.8 |
Prepaid expenses and other current assets | 49.9 |  |  | 24.0 |  |  | 54.0 |  |  | (18.6 | ) |  | 109.3 |
Total current assets | 70.5 |  |  | 298.9 |  |  | 303.7 |  |  | (18.6 | ) |  | 654.5 |
Property and equipment, net | 41.6 |  |  | 979.7 |  |  | 370.5 |  |  | — |  |  | 1,391.8 |
Goodwill | — |  |  | 858.4 |  |  | 1,068.8 |  |  | — |  |  | 1,927.2 |
Intangible assets, net | 12.0 |  |  | 115.5 |  |  | 283.8 |  |  | — |  |  | 411.3 |
Deferred income tax assets | 90.9 |  |  | 57.6 |  |  | — |  |  | (72.7 | ) |  | 75.8 |
Other long-term assets | 49.0 |  |  | 95.1 |  |  | 77.2 |  |  | — |  |  | 221.3 |
Intercompany notes receivable | 528.8 |  |  | — |  |  | — |  |  | (528.8 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,855.5 |  |  | 107.7 |  |  | — |  |  | (2,963.2 | ) |  | — |
Total assets | $ | 3,648.3 |  |  | $ | 2,512.9 |  |  | $ | 2,104.0 |  |  | $ | (3,583.3 | ) |  | $ | 4,681.9 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 40.0 |  |  | $ | 6.4 |  |  | $ | 8.2 |  |  | $ | (17.5 | ) |  | $ | 37.1 |
Accounts payable | 7.0 |  |  | 37.2 |  |  | 24.1 |  |  | — |  |  | 68.3 |
Accrued payroll | 31.6 |  |  | 57.3 |  |  | 58.4 |  |  | — |  |  | 147.3 |
Accrued interest payable | 22.8 |  |  | 2.8 |  |  | 0.2 |  |  | — |  |  | 25.8 |
Other current liabilities | 96.3 |  |  | 21.6 |  |  | 80.3 |  |  | (1.1 | ) |  | 197.1 |
Total current liabilities | 197.7 |  |  | 125.3 |  |  | 171.2 |  |  | (18.6 | ) |  | 475.6 |
Long-term debt, net of current portion | 2,679.2 |  |  | 248.9 |  |  | 51.2 |  |  | — |  |  | 2,979.3 |
Intercompany notes payable | — |  |  | — |  |  | 528.8 |  |  | (528.8 | ) |  | — |
Self-insured risks | 14.1 |  |  | — |  |  | 96.3 |  |  | — |  |  | 110.4 |
Other long-term liabilities | 21.4 |  |  | 15.2 |  |  | 85.3 |  |  | (72.3 | ) |  | 49.6 |
Intercompany payable | — |  |  | — |  |  | 167.6 |  |  | (167.6 | ) |  | — |
| 2,912.4 |  |  | 389.4 |  |  | 1,100.4 |  |  | (787.3 | ) |  | 3,614.9 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 138.3 |  |  | — |  |  | 138.3 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 735.9 |  |  | 2,123.5 |  |  | 672.5 |  |  | (2,796.0 | ) |  | 735.9 |
Noncontrolling interests | — |  |  | — |  |  | 192.8 |  |  | — |  |  | 192.8 |
Total shareholders’ equity | 735.9 |  |  | 2,123.5 |  |  | 865.3 |  |  | (2,796.0 | ) |  | 928.7 |
Total liabilities and shareholders’ equity | $ | 3,648.3 |  |  | $ | 2,512.9 |  |  | $ | 2,104.0 |  |  | $ | (3,583.3 | ) |  | $ | 4,681.9 |
Condensed Consolidating Statement of Cash Flows |
| For the Year Ended December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 27.6 |  |  | $ | 381.3 |  |  | $ | 248.3 |  |  | $ | — |  |  | $ | 657.2 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (10.9 | ) |  | — |  |  | (27.9 | ) |  | — |  |  | (38.8 | )
Purchases of property and equipment | (39.4 | ) |  | (106.1 | ) |  | (80.3 | ) |  | — |  |  | (225.8 | )
Additions to capitalized software costs | (16.3 | ) |  | (0.2 | ) |  | (2.7 | ) |  | — |  |  | (19.2 | )
Proceeds from disposal of assets | — |  |  | 11.7 |  |  | 0.6 |  |  | — |  |  | 12.3 |
Purchases of restricted investments | — |  |  | — |  |  | (8.5 | ) |  | — |  |  | (8.5 | )
Net change in restricted cash | — |  |  | — |  |  | (1.5 | ) |  | — |  |  | (1.5 | )
Proceeds from repayment of intercompany note receivable | 51.0 |  |  | — |  |  | — |  |  | (51.0 | ) |  | — |
Other | (3.7 | ) |  | — |  |  | 0.7 |  |  | — |  |  | (3.0 | )
Net cash used in investing activities | (19.3 | ) |  | (94.6 | ) |  | (119.6 | ) |  | (51.0 | ) |  | (284.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (126.9 | ) |  | — |  |  | (3.0 | ) |  | — |  |  | (129.9 | )
Principal payments on intercompany note payable | — |  |  | — |  |  | (51.0 | ) |  | 51.0 |  |  | — |
Borrowings on revolving credit facility | 273.3 |  |  | — |  |  | — |  |  | — |  |  | 273.3 |
Payments on revolving credit facility | (330.3 | ) |  | — |  |  | — |  |  | — |  |  | (330.3 | )
Principal payments under capital lease obligations | — |  |  | (6.8 | ) |  | (8.5 | ) |  | — |  |  | (15.3 | )
Debt amendment and issuance costs | (3.1 | ) |  | — |  |  | — |  |  | — |  |  | (3.1 | )
Repurchases of common stock, including fees and expenses | (38.1 | ) |  | — |  |  | — |  |  | — |  |  | (38.1 | )
Dividends paid on common stock | (91.5 | ) |  | — |  |  | — |  |  | — |  |  | (91.5 | )
Proceeds from exercising stock warrants | 26.6 |  |  | — |  |  | — |  |  | — |  |  | 26.6 |
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (51.9 | ) |  | — |  |  | (51.9 | )
Taxes paid on behalf of employees for shares withheld | (19.5 | ) |  | — |  |  | (0.3 | ) |  | — |  |  | (19.8 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 20.8 |  |  | — |  |  | 20.8 |
Other | 1.1 |  |  | — |  |  | (0.7 | ) |  | — |  |  | 0.4 |
Change in intercompany advances | 313.8 |  |  | (278.6 | ) |  | (35.2 | ) |  | — |  |  | — |
Net cash provided by (used in) financing activities | 5.4 |  |  | (285.4 | ) |  | (129.8 | ) |  | 51.0 |  |  | (358.8 | )
Increase (decrease) in cash and cash equivalents | 13.7 |  |  | 1.3 |  |  | (1.1 | ) |  | — |  |  | 13.9 |
Cash and cash equivalents at beginning of year | 20.6 |  |  | 1.6 |  |  | 18.3 |  |  | — |  |  | 40.5 |
Cash and cash equivalents at end of year | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Supplemental schedule of noncash financing activity: |  |  |  |  |  |  |  |  |
Conversion of convertible debt | $ | 319.4 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 319.4 |
| For the Year Ended December 31, 2016
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 65.8 |  |  | $ | 327.4 |  |  | $ | 241.2 |  |  | $ | — |  |  | $ | 634.4 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | — |  |  | — |  |  | (48.1 | ) |  | — |  |  | (48.1 | )
Purchases of property and equipment | (21.8 | ) |  | (77.4 | ) |  | (78.5 | ) |  | — |  |  | (177.7 | )
Additions to capitalized software costs | (22.8 | ) |  | (0.2 | ) |  | (2.2 | ) |  | — |  |  | (25.2 | )
Proceeds from disposal of assets | — |  |  | 0.7 |  |  | 23.2 |  |  | — |  |  | 23.9 |
Purchases of restricted investments | — |  |  | — |  |  | (1.3 | ) |  | — |  |  | (1.3 | )
Net change in restricted cash | — |  |  | — |  |  | (15.1 | ) |  | — |  |  | (15.1 | )
Funding of intercompany note receivable | (22.5 | ) |  | — |  |  | — |  |  | 22.5 |  |  | — |
Proceeds from repayment of intercompany note receivable | 52.0 |  |  | — |  |  | — |  |  | (52.0 | ) |  | — |
Other | (3.7 | ) |  | (0.2 | ) |  | 2.3 |  |  | — |  |  | (1.6 | )
Net cash provided by investing activities of discontinued operations | 0.1 |  |  | — |  |  | — |  |  | — |  |  | 0.1 |
Net cash used in investing activities | (18.7 | ) |  | (77.1 | ) |  | (119.7 | ) |  | (29.5 | ) |  | (245.0 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on debt, including pre-payments | (198.5 | ) |  | (1.3 | ) |  | (2.3 | ) |  | — |  |  | (202.1 | )
Principal borrowings on intercompany notes payable | — |  |  | — |  |  | 22.5 |  |  | (22.5 | ) |  | — |
Principal payments on intercompany notes payable | — |  |  | — |  |  | (52.0 | ) |  | 52.0 |  |  | — |
Borrowings on revolving credit facility | 335.0 |  |  | — |  |  | — |  |  | — |  |  | 335.0 |
Payments on revolving credit facility | (313.0 | ) |  | — |  |  | — |  |  | — |  |  | (313.0 | )
Principal payments under capital lease obligations | (0.1 | ) |  | (5.9 | ) |  | (7.3 | ) |  | — |  |  | (13.3 | )
Repurchases of common stock, including fees and expenses | (65.6 | ) |  | — |  |  | — |  |  | — |  |  | (65.6 | )
Dividends paid on common stock | (83.8 | ) |  | — |  |  | — |  |  | — |  |  | (83.8 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (64.9 | ) |  | — |  |  | (64.9 | )
Taxes paid on behalf of employees for shares withheld | (11.6 | ) |  | — |  |  | — |  |  | — |  |  | (11.6 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 3.5 |  |  | — |  |  | 3.5 |
Other | 6.9 |  |  | — |  |  | (1.6 | ) |  | — |  |  | 5.3 |
Change in intercompany advances | 263.0 |  |  | (242.7 | ) |  | (20.3 | ) |  | — |  |  | — |
Net cash used in financing activities | (67.7 | ) |  | (249.9 | ) |  | (122.4 | ) |  | 29.5 |  |  | (410.5 | )
(Decrease) increase in cash and cash equivalents | (20.6 | ) |  | 0.4 |  |  | (0.9 | ) |  | — |  |  | (21.1 | )
Cash and cash equivalents at beginning of year | 41.2 |  |  | 1.2 |  |  | 19.2 |  |  | — |  |  | 61.6 |
Cash and cash equivalents at end of year | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 18.3 |  |  | $ | — |  |  | $ | 40.5 |
| For the Year Ended December 31, 2015
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 59.7 |  |  | $ | 214.6 |  |  | $ | 227.7 |  |  | $ | — |  |  | $ | 502.0 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of businesses, net of cash acquired | (954.6 | ) |  | — |  |  | (30.5 | ) |  | — |  |  | (985.1 | )
Purchases of property and equipment | (15.9 | ) |  | (62.0 | ) |  | (50.5 | ) |  | — |  |  | (128.4 | )
Additions to capitalized software costs | (24.5 | ) |  | (0.4 | ) |  | (3.2 | ) |  | — |  |  | (28.1 | )
Proceeds from disposal of assets | — |  |  | 3.5 |  |  | 0.5 |  |  | — |  |  | 4.0 |
Proceeds from sale of nonrestricted marketable securities | 12.8 |  |  | — |  |  | — |  |  | — |  |  | 12.8 |
Purchases of restricted investments | — |  |  | — |  |  | (7.1 | ) |  | — |  |  | (7.1 | )
Net change in restricted cash | — |  |  | — |  |  | 2.7 |  |  | — |  |  | 2.7 |
Funding of intercompany note receivable | (2.0 | ) |  | — |  |  | — |  |  | 2.0 |  |  | — |
Proceeds from repayment of intercompany note receivable | 24.0 |  |  | — |  |  | — |  |  | (24.0 | ) |  | — |
Other | (0.5 | ) |  | (1.9 | ) |  | 1.3 |  |  | — |  |  | (1.1 | )
Net cash provided by investing activities of discontinued operations | 0.5 |  |  | — |  |  | — |  |  | — |  |  | 0.5 |
Net cash used in investing activities | (960.2 | ) |  | (60.8 | ) |  | (86.8 | ) |  | (22.0 | ) |  | (1,129.8 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal borrowings on term loan facilities | 250.0 |  |  | — |  |  | — |  |  | — |  |  | 250.0 |
Proceeds from bond issuance | 1,400.0 |  |  | — |  |  | — |  |  | — |  |  | 1,400.0 |
Principal payments on debt, including pre-payments | (595.0 | ) |  | (1.6 | ) |  | (0.8 | ) |  | — |  |  | (597.4 | )
Principal borrowings on intercompany notes payable | — |  |  | — |  |  | 2.0 |  |  | (2.0 | ) |  | — |
Principal payments on intercompany notes payable | — |  |  | — |  |  | (24.0 | ) |  | 24.0 |  |  | — |
Borrowings on revolving credit facility | 540.0 |  |  | — |  |  | — |  |  | — |  |  | 540.0 |
Payments on revolving credit facility | (735.0 | ) |  | — |  |  | — |  |  | — |  |  | (735.0 | )
Principal payments under capital lease obligations | (0.3 | ) |  | (4.5 | ) |  | (6.2 | ) |  | — |  |  | (11.0 | )
Debt amendment and issuance costs | (31.9 | ) |  | — |  |  | — |  |  | — |  |  | (31.9 | )
Repurchases of common stock, including fees and expenses | (45.3 | ) |  | — |  |  | — |  |  | — |  |  | (45.3 | )
Dividends paid on common stock | (77.2 | ) |  | — |  |  | — |  |  | — |  |  | (77.2 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (54.4 | ) |  | — |  |  | (54.4 | )
Taxes paid on behalf of employees for shares withheld | (17.2 | ) |  | — |  |  | — |  |  | — |  |  | (17.2 | )
Contributions from consolidated affiliates | — |  |  | — |  |  | 3.0 |  |  | — |  |  | 3.0 |
Other | (0.9 | ) |  | 1.5 |  |  | (1.5 | ) |  | — |  |  | (0.9 | )
Change in intercompany advances | 212.6 |  |  | (149.4 | ) |  | (63.2 | ) |  | — |  |  | — |
Net cash provided by (used in) financing activities | 899.8 |  |  | (154.0 | ) |  | (145.1 | ) |  | 22.0 |  |  | 622.7 |
Decrease in cash and cash equivalents | (0.7 | ) |  | (0.2 | ) |  | (4.2 | ) |  | — |  |  | (5.1 | )
Cash and cash equivalents at beginning of year | 41.9 |  |  | 1.4 |  |  | 23.4 |  |  | — |  |  | 66.7 |
Cash and cash equivalents at end of year | $ | 41.2 |  |  | $ | 1.2 |  |  | $ | 19.2 |  |  | $ | — |  |  | $ | 61.6 |
Supplemental schedule of noncash financing activities: |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock | $ | 93.2 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 93.2 |
Intercompany note activity | $ | (183.5 | ) |  | $ | — |  |  | $ | 183.5 |  |  | $ | — |  |  | $ | — |

X
- References No definition available. + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration